Rossella Marino

Rossella Marino

Auto-generated profile, based on publicly available information

Rossella Marino

From the Emergency Medicine Department, 2nd Medical School, University “La Sapienza,” Sant'Andrea Hospital Rome, Italy

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2014 in Critical Care
Verified
Journal Article
Open access
PDF file
RMRossella Marino
Rossella Marino
JSJoachim Struck
Joachim Struck
AMAlan S Maisel
Alan S Maisel
LMLaura Magrini
Laura Magrini
ABAndreas Bergmann
Andreas Bergmann
Salvatore Di SommaSalvatore Di Somma
Salvatore Di Somma
Introduction: The incidence of death among patients admitted for severe sepsis or septic shock is high. Adrenomedullin (ADM) plays a central role in initiating the hyperdynamic response during the early stages of sepsis. Pilot studies indicate an association of plasma ADM with the severity of the disease. In the present study we utilized a novel sandwich immunoassay of bioactive plasma ADM in patients hospitalized with sepsis in order to assess the clinical utility. Methods: We enrolled 101 consecutive patients admitted to the emergency department with suspected sepsis in this study. Sepsis was defined by fulfillment of at least two systemic inflammatory response syndrome (SIRS) criteria plus clinical suspicion of infection. Plasma samples for ADM measurement were obtained on admission and for the next four days. The 28-day mortality rate was recorded. Results: ADM at admission was associated with severity of disease (correlation with Acute Physiology and Chronic Health Evaluation II (APACHE II) score: r = 0.46; P <0.0001). ADM was also associated with 28-day mortality (ADM median (IQR): survivors: 50 (31 to 77) pg/mL; non-survivors: 84 (48 to 232) pg/mL; P <0.001) and was independent from and additive to APACHE II (P = 0.02). Cox regression analysis revealed an additive value of serial measurement of ADM over baseline assessment for prediction of 28-day mortality (P < 0.01). ADM was negatively correlated with mean arterial pressure (r = -0.39; P <0.0001), and it strongly discriminated those patients requiring vasopressor therapy from the others (ADM median (IQR): no vasopressors 48 (32 to 75) pg/mL; with vasopressors 129 (83 to 264) pg/mL, P <0.0001). Conclusions: In patients admitted with sepsis, severe sepsis or septic shock plasma ADM is strongly associated with severity of disease, vasopressor requirement and 28-day mortality.

1 July 1999 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
FVFrancesco Violi
Francesco Violi
RMR. Marino
R. Marino
MMM.T. Milite
M.T. Milite
Lorenzo LoffredoLorenzo Loffredo
Lorenzo Loffredo
Nitric oxide (NO) is a free radical with an unpaired electron in the highest orbital. This is why it behaves as a potential antioxidant agent by virtue of its ability to reduce other molecules. In vitro experiments support this concept inasmuch as NO is able to inhibit lipid peroxidation. However, NO is rapidly inactivated by the superoxide anion (O) to form peroxynitrite (ONOO−), which is a potent oxidant. Therefore, in the presence of O, NO behaves as a potent pro‐oxidant. This is the mechanism that accounts for the low density lipoprotein (LDL) oxidation that occurs when NO and O are simultaneously present in the medium. As NO and O are simultaneously released by cells such as endothelial cells, the balance between these two radicals is crucial in understanding the net effect of NO on lipid peroxidation. Thus an excess of NO will favour lipid peroxidation inhibition, while an excess of O or equimolar concentration of NO and O will induce lipid peroxidation. Modulation of this balance may have important clinical implications, particularly in the atherosclerotic process in which oxidant stress seems to play a pivotal role in the onset and progression of vascular lesions. Copyright © 1999 John Wiley & Sons, Ltd.

1 January 2014 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
LMLaura Magrini
Laura Magrini
GGGiulia Gagliano
Giulia Gagliano
FTFrancesco Travaglino
Francesco Travaglino
FVFrancesco Vetrone
Francesco Vetrone
RMRossella Marino
Rossella Marino
SSSalvatore Di Somma
Salvatore Di Somma
Background: Procalcitonin (PCT) is currently the most studied infection biomarker and its blood levels seem to mirror the severity of illness and outcome. PCT is widely used together with other biomarkers, such as white blood cells (WBC) count and C reactive protein (CRP), in order to guide antibiotic therapy. This study aimed to verify the diagnostic and prognostic power of WBC, CRP and PCT in patients with suspected infection in emergency department (ED). Methods: A total of 513 patients presenting to the ED with signs/symptoms of local infections or sepsis were enrolled. APACHEII score and in-hospital death were recorded. Patients were subdivided into quartiles by age, and the biomarkers were measured at baseline. Receiver operating characteristics (ROC) curves for evaluating diagnostic and prognostic role of PCT, CRP and WBC were calculated for each variable alone and combined. Results: When compared each other for PCT, CRP, and WBC there was no significant difference between the four subgroups. A direct correlation between PCT and WBC was found in the II, III, and IV quartiles (the highest correlation, r=0.34, p<0.0003). PCT alone or when combined with WBC showed the best diagnostic and prognostic power at ROC analysis. Conclusions: Our data demonstrate that WBC, but more CRP and PCT are reliable diagnostic and prognostic biomarkers, when considered in combination and with severity clinical score. PCT confirms its stronger usefulness as a diagnostic marker of sepsis. A multi-diagnostic tools approach is fundamental to perform a correct and rapid diagnosis of infection and sepsis in ED.

9 December 2014 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
RMRossella Marino
Rossella Marino
JSJoachim Struck
Joachim Struck
OHOliver Hartmann
Oliver Hartmann
AMAlan S. Maisel
Alan S. Maisel
MRMiriam Rehfeldt
Miriam Rehfeldt
Salvatore Di SommaSalvatore Di Somma
Salvatore Di Somma
Acute kidney injury (AKI) aggravates the prognosis of patients with sepsis. Reliable biomarkers for early detection of AKI in this setting are lacking. Enkephalins influence kidney function, and may have a role in AKI from sepsis. We utilized a novel immunoassay for plasma proenkephalin (pro-ENK), a stable surrogate marker for endogenous enkephalins, in patients hospitalized with sepsis, in order to assess its clinical utility.

12 February 2013 in Critical Care
Verified
Journal Article
Open access
PDF file
Salvatore Di SommaSalvatore Di Somma
Salvatore Di Somma
LMLaura Magrini
Laura Magrini
BBBenedetta De Berardinis
Benedetta De Berardinis
RMRossella Marino
Rossella Marino
EFEnrico Ferri
Enrico Ferri
ESEnrico Di Stasio
Enrico Di Stasio
Introduction Acute kidney injury (AKI) is a common complication among hospitalized patients. The aim of this study was to evaluate the utility of blood neutrophil gelatinase-associated lipocalin (NGAL) assessment as an aid in the early risk evaluation for AKI development in admitted patients. Methods This is a multicenter Italian prospective emergency department (ED) cohort study in which we enrolled 665 patients admitted to hospital from the ED. Results Blood NGAL and serum creatinine (sCr) were determined at ED presentation (T0), and at: 6 (T6), 12 (T12), 24 (T24) and 72 (T72) hours after hospitalization. A preliminary assessment of AKI by the treating ED physician occurred in 218 out of 665 patients (33%), while RIFLE AKI by expert nephrologists was confirmed in 49 out of 665 patients (7%). The ED physician's initial judgement lacked sensitivity and specificity, overpredicting the diagnosis of AKI in 27% of the cohort, while missing 20% of those with AKI as a final diagnosis. The area under the receiver operating characteristic curve (AUC), obtained at T0, for blood NGAL alone in the AKI group was 0.80. When NGAL at T0 was added to the ED physician's initial clinical judgment the AUC was increased to 0.90, significantly greater when compared to the AUC of the T0 estimated glomerular filtration rate (eGFR) obtained either by modification of diet in renal disease (MDRD) equation (0.78) or Cockroft-Gault formula (0.78) (P = 0.022 and P = 0.020 respectively). The model obtained by combining NGAL with the ED physician's initial clinical judgement compared to the model combining sCr with the ED physician's initial clinical judgement, resulted in a net reclassification index of 32.4 percentage points. Serial assessment of T0 and T6 hours NGAL provided a high negative predictive value (NPV) (98%) in ruling out the diagnosis of AKI within 6 hours of patients' ED arrival. NGAL (T0) showed the strongest predictive value for in-hospital patient's mortality at a cutoff of 400 ng/ml. Conclusions Our study demonstrated that assessment of a patient's initial blood NGAL when admitted to hospital from the ED improved the initial clinical diagnosis of AKI and predicted in-hospital mortality. Blood NGAL assessment coupled with the ED physician's clinical judgment may prove useful in deciding the appropriate strategies for patients at risk for the development of AKI. See related commentary by Legrand et al.,http://ccforum.com/content/17/2/132

1 September 2017 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
HKHanah Kim
Hanah Kim
Mina HurMina Hur
Mina Hur
Seungho LeeSeungho Lee
Seungho Lee
RMRossella Marino
Rossella Marino
LMLaura Magrini
Laura Magrini
GNGreat Network
Great Network
Kim H, et al. Ann Lab Med. 2017 Sep;37(5):388-397. https://doi.org/10.3343/alm.2017.37.5.388